// App-Quantinova.ai

2581 : Safety of Hydroxychloroquine Withdrawal in Older Adults with Systemic Lupus Erythematosus

Researchers

Presenter

  • Anna Zezon

Principal Investigators

  • Peter M. Izmirly

  • Nicole Bornkamp

  • Chung-E Tseng

  • H. Michael Belmont

  • Anca Askanase

  • Jane E. Salmon

  • Michael Lockshin

  • Jill P. Buyon

Medical Centers

  • Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY

  • New York University School of Medicine, New York, NY

  • New York University School of Medicine, New York, NY

  • Department of Pathology, New York University School of Medicine, New York, NY

  • Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, NY

  • Division of Rheumatology, Hospital for Special Surgery, New York, NY

  • Rheumatology, Barbara Volcker Center for Women and Rheumatic Diseases: Hospital for Special Surgery, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A